Phenotypeca is delighted to appoint Patrick Florent from GSK Vaccines and patent attorney Anton Hutter to our Advisory Board

November 2019

We are delighted to announce two powerful additions to the Phenotypeca Advisory Board.  Patrick Florent, an executive with a broad and diverse experience in Industrial Operation, Enterprise Integration and Global Alliances at GSK Vaccines, provides outstanding strategic direction for one of our key market areas.  Anton Hutter, a European & UK patent attorney and partner in Venner Shipley’s Chemical & Life Sciences team, provides Intellectual Property expertise across all of our market areas. He has expertise in biotechnology and pharmaceuticals; in particular, he has a deep understanding of yeast molecular biology, biochemistry & genetics, including therapeutic antibodies and diagnostics, peptides and vaccines.